Annual ROE
127.51%
+352.05%+156.79%
December 31, 2023
Summary
- As of February 7, 2025, FHTX annual return on equity is 127.51%, with the most recent change of +352.05% (+156.79%) on December 31, 2023.
- During the last 3 years, FHTX annual ROE has risen by +364.05% (+153.91%).
- FHTX annual ROE is now at all-time high.
Performance
FHTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
167.93%
+27.59%+19.66%
September 30, 2024
Summary
- As of February 7, 2025, FHTX quarterly return on equity is 167.93%, with the most recent change of +27.59% (+19.66%) on September 30, 2024.
- Over the past year, FHTX quarterly ROE has dropped by -146.69% (-46.62%).
- FHTX quarterly ROE is now -81.87% below its all-time high of 926.28%, reached on June 30, 2023.
Performance
FHTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
FHTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +156.8% | -46.6% |
| 3 y3 years | +153.9% | +135.8% |
| 5 y5 years | +90.1% | +135.8% |
FHTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +156.8% | -81.9% | +135.8% |
| 5 y | 5-year | at high | +153.9% | -81.9% | +125.2% |
| alltime | all time | at high | +153.9% | -81.9% | +125.2% |
Foghorn Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 167.93%(+19.7%) |
| Jun 2024 | - | 140.34%(+6.2%) |
| Mar 2024 | - | 132.12%(-30.0%) |
| Dec 2023 | 127.51%(-156.8%) | 188.81%(-40.0%) |
| Sep 2023 | - | 314.62%(-66.0%) |
| Jun 2023 | - | 926.28%(-297.5%) |
| Mar 2023 | - | -469.03%(+107.9%) |
| Dec 2022 | -224.54% | -225.58%(+33.2%) |
| Sep 2022 | - | -169.36%(+24.4%) |
| Jun 2022 | - | -136.11%(+24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -109.72%(+19.9%) |
| Dec 2021 | -83.37%(-64.8%) | -91.54%(-36.3%) |
| Sep 2021 | - | -143.77%(-12.2%) |
| Jun 2021 | - | -163.68%(-17.9%) |
| Mar 2021 | - | -199.39%(-70.1%) |
| Dec 2020 | -236.54%(-507.2%) | -666.30%(-812.7%) |
| Sep 2020 | - | 93.49%(-43.7%) |
| Jun 2020 | - | 166.11%(+245.3%) |
| Mar 2020 | - | 48.10%(+49.1%) |
| Dec 2019 | 58.09%(-13.4%) | 32.25% |
| Dec 2018 | 67.06% | - |
FAQ
- What is Foghorn Therapeutics annual return on equity?
- What is the all time high annual ROE for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual ROE year-on-year change?
- What is Foghorn Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly ROE year-on-year change?
What is Foghorn Therapeutics annual return on equity?
The current annual ROE of FHTX is 127.51%
What is the all time high annual ROE for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual return on equity is 127.51%
What is Foghorn Therapeutics annual ROE year-on-year change?
Over the past year, FHTX annual return on equity has changed by +352.05% (+156.79%)
What is Foghorn Therapeutics quarterly return on equity?
The current quarterly ROE of FHTX is 167.93%
What is the all time high quarterly ROE for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly return on equity is 926.28%
What is Foghorn Therapeutics quarterly ROE year-on-year change?
Over the past year, FHTX quarterly return on equity has changed by -146.69% (-46.62%)